This 12-week randomized, single-blind, placebo-controlled trial assessed the efficacy and safety of Caralluma fimbriata extract (CFE) in 89 overweight and obese individuals. Participants received either 1 g/day of CFE or a matching placebo. Both groups exhibited numerical reductions in weight, BMI, waist and hip circumference, and waist-hip ratio; however, these
